Massimo Travaglini

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis)

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli et al. · Frontiers in Immunology · 2024 · 49 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—<scp>IL PSO</scp> (<scp>Italian landscape psoriasis</scp>)

Alessandra Narcisi, Mario Valenti, Luigi Gargiulo et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 44 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli et al. · Frontiers in Medicine · 2023 · 27 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Treatment of Psoriasis with Different Dosage Regimens of Etanercept: Preliminary Results from the TαRanta Plastic Study Group

Nicoletta Cassano, Francesco Loconsole, A Miracapillo et al. · International Journal of Immunopathology and Pharmacology · 2010 · 26 citations

Medicine, Pharmacology, Pharmacotherapy +11

Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS)

Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli et al. · Journal of Clinical Medicine · 2024 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13